Understanding Malignancies of the Thyroid Gland: Institutional Experience.

Jaimanti Bakshi, Sourabha Kumar Patro, Navjot Kaur, Naresh Kumar Panda, Grace Budhiraja
Author Information
  1. Jaimanti Bakshi: 1Department of Otolaryngology and Head Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  2. Sourabha Kumar Patro: 1Department of Otolaryngology and Head Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  3. Navjot Kaur: 1Department of Otolaryngology and Head Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  4. Naresh Kumar Panda: 1Department of Otolaryngology and Head Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  5. Grace Budhiraja: 1Department of Otolaryngology and Head Neck Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Abstract

To study the epidemiological, pathological characters and determine survival in patients diagnosed of having thyroid gland malignancies. Retrospective chart review of patients having thyroid gland malignancies, which were managed by the two senior authors at our tertiary care institute from January 2000 to December 2006, were performed and evaluated in terms of various clinical, operative and histological parameters. Patients in which follow up of at least 10 years are available were included in the study. Survival was enquired telephonically in those patients who got cured and did not consent to come for follow up. Slides were reviewed. Statistical analysis was done using SPSS statistical software. Kaplan-Meier method was used for calculating survival. A total of 182 patients were included in the study. Papillary carcinoma was the commonest malignant lesion with a frequency of 87.91% followed by follicular carcinoma (7.69%), medullary carcinoma (3.29%) and anaplastic carcinoma (1.09%). Female predominance was seen (F:M-5.06:1). The 5 year and 10 year survival rates were 89% and 73% respectively. The most common postoperative squeal was transient hypocalcaemia, seen in (27/182) 15% patients which was followed by permanent hypocalcaemia 16/182 (8.79%), transient recurrent laryngeal nerve paresis 12/182 (6.59%) and permanent recurrent laryngeal nerve palsy 8/182 (4.39%). Thyroid malignancies affect all age groups and have good long term prognosis. Management yields promising results and hence early and adequate treatment is emphasized.

Keywords

References

  1. Mymensingh Med J. 2016 Jan;25(1):39-44 [PMID: 26931247]
  2. Eur J Cancer. 2016 May;59:34-45 [PMID: 27014798]
  3. Georgian Med News. 2016 Mar;(252):89-95 [PMID: 27119842]
  4. Cancer. 1990 Jul 15;66(2):321-30 [PMID: 1695118]
  5. Genes Chromosomes Cancer. 1992 Oct;5(3):212-8 [PMID: 1384673]
  6. CA Cancer J Clin. 2009 Mar-Apr;59(2):99-110 [PMID: 19278960]
  7. Surg Oncol Clin N Am. 2006 Jul;15(3):661-79, x [PMID: 16882503]
  8. Radiology. 2005 Dec;237(3):794-800 [PMID: 16304103]
  9. J Clin Endocrinol Metab. 1988 Sep;67(3):501-8 [PMID: 3410936]
  10. World J Surg. 1992 Jul-Aug;16(4):669-74; discussion 774-5 [PMID: 1413835]
  11. Virchows Arch. 2005 Nov;447(5):787-93 [PMID: 16189702]
  12. Nihon Ika Daigaku Zasshi. 1999 Oct;66(5):319-23 [PMID: 10548000]
  13. Am J Med. 1994 Nov;97(5):418-28 [PMID: 7977430]
  14. J Clin Endocrinol Metab. 2003 Jul;88(7):3184-9 [PMID: 12843163]
  15. Head Neck. 2016 Apr;38 Suppl 1:E1122-9 [PMID: 26879282]
  16. Cytojournal. 2008 Apr 07;5:6 [PMID: 18394201]
  17. Ann Surg Oncol. 2006 Apr;13(4):453-64 [PMID: 16474910]
  18. J Clin Endocrinol Metab. 2012 Jun;97(6):E878-87 [PMID: 22496497]
  19. CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49 [PMID: 19474385]
  20. Klin Khir. 2015 Jun;(6):49-54 [PMID: 26521469]
  21. Ann Surg. 2007 Sep;246(3):375-81; discussion 381-4 [PMID: 17717441]
  22. Lancet. 2003 Feb 8;361(9356):501-11 [PMID: 12583960]
  23. Surgery. 2004 Sep;136(3):609-16 [PMID: 15349109]
  24. Cancer. 1998 Dec 15;83(12):2638-48 [PMID: 9874472]
  25. Thyroid. 2003 Oct;13(10):949-58 [PMID: 14611704]
  26. Curr Probl Surg. 2008 Mar;45(3):156-250 [PMID: 18346477]
  27. Thyroid. 2006 Feb;16(2):109-42 [PMID: 16420177]
  28. Radiat Res. 1995 Mar;141(3):259-77 [PMID: 7871153]
  29. Thyroid. 2004 Mar;14(3):207-15 [PMID: 15072703]
  30. Cancer. 2005 Apr 1;103(7):1330-5 [PMID: 15739211]
  31. Otolaryngol Clin North Am. 1990 Jun;23(3):453-73 [PMID: 1973281]
  32. Surgery. 2016 Aug;160(2):405-12 [PMID: 27157121]
  33. Oncologist. 2007 Jan;12(1):20-37 [PMID: 17227898]
  34. Am J Clin Pathol. 2009 Nov;132(5):658-65 [PMID: 19846805]
  35. Thyroid. 2007 Jun;17(6):595-6; author reply 596-7 [PMID: 17614785]
  36. Cancer. 2003 Mar 1;97(5):1186-94 [PMID: 12599224]
  37. Ann Intern Med. 1968 Sep;69(3):537-40 [PMID: 5673172]
  38. J Clin Endocrinol Metab. 1997 Dec;82(12):4020-7 [PMID: 9398706]
  39. Arch Otolaryngol Head Neck Surg. 2002 Nov;128(11):1275-8 [PMID: 12431169]
  40. Endocrinol Metab (Seoul). 2015 Sep;30(3):252-62 [PMID: 26435130]
  41. Oncol Lett. 2016 Apr;11(4):2699-2705 [PMID: 27073540]
  42. Endocr Relat Cancer. 2008 Mar;15(1):37-49 [PMID: 18310274]
  43. BMJ Open. 2015 Dec 07;5(12):e009843 [PMID: 26644126]
  44. Cancer. 1996 Nov 15;78(10):2184-92 [PMID: 8918413]
  45. N Engl J Med. 2004 Oct 21;351(17):1764-71 [PMID: 15496625]
  46. Radiology. 2000 Jun;215(3):801-6 [PMID: 10831702]
  47. Curr Med Res Opin. 2016 Jul;32(7):1291-301 [PMID: 27010079]
  48. JAMA Otolaryngol Head Neck Surg. 2016 May 1;142(5):472-8 [PMID: 27031884]
  49. Thyroid. 2006 Dec;16(12):1229-42 [PMID: 17199433]
  50. Radiats Biol Radioecol. 2015 Jul-Aug;55(4):355-88 [PMID: 26601537]
  51. JAMA. 2004 Dec 1;292(21):2632-42 [PMID: 15572721]
  52. N Engl J Med. 1993 Feb 25;328(8):553-9 [PMID: 8426623]
  53. J Surg Oncol. 2015 Dec;112(8):828-33 [PMID: 26493240]
  54. Cancer. 2001 Feb 1;91(3):505-24 [PMID: 11169933]
  55. Clin Endocrinol (Oxf). 1977 Dec;7(6):481-93 [PMID: 598014]
  56. Ann Surg Oncol. 2005 Jan;12(1):81-9 [PMID: 15827782]

Word Cloud

Created with Highcharts 10.0.0thyroidglandpatientsmalignanciescarcinomastudysurvivalThyroidcancersfollowincludedSurvivalfollowedseentransienthypocalcaemiapermanentrecurrentlaryngealnerveepidemiologicalpathologicalcharactersdeterminediagnosedRetrospectivechartreviewmanagedtwoseniorauthorstertiarycareinstituteJanuary2000December2006performedevaluatedtermsvariousclinicaloperativehistologicalparametersPatientsleast10 yearsavailableenquiredtelephonicallygotcuredconsentcomeSlidesreviewedStatisticalanalysisdoneusingSPSSstatisticalsoftwareKaplan-Meiermethodusedcalculatingtotal182Papillarycommonestmalignantlesionfrequency8791%follicular769%medullary329%anaplastic109%FemalepredominanceF:M-506:15 year10 yearrates89%73%respectivelycommonpostoperativesqueal27/18215%16/182879%paresis12/182659%palsy8/182439%affectagegroupsgoodlongtermprognosisManagementyieldspromisingresultshenceearlyadequatetreatmentemphasizedUnderstandingMalignanciesGland:InstitutionalExperienceDiagnosticdisparitieslesionsDifferentiateddedifferentiatedMetastasis

Similar Articles

Cited By